Surface Oncology

YTD

ALL

Why Robinhood?

You can watch SURF and buy or sell other stocks, ETFs, and their options commission-free!

About SURF

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune evasion.

CEO

Robert W. Ross, MD

CEORobert W. Ross, MD

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2014

Founded2014

Employees

—

Employees—

SURF Key Statistics

Market cap

65.08M

Market cap65.08M

Price-Earnings ratio

-0.70

Price-Earnings ratio-0.70

Dividend yield

—

Dividend yield—

Average volume

292.98K

Average volume292.98K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.43

52 Week high$1.43

52 Week low

$0.555

52 Week low$0.555